Story excerpt provided by Crain’s Cleveland Business.
GenomOncology, a Cleveland company that has developed a technology platform to streamline the use of next-generation sequencing data in medical care and research, hopes to get a boost in the United Kingdom through a new partnership.
On Thursday, Nov. 5, GenomOncology and Cambridge, England-based Congenica, a developer of genome-based discovery and diagnostic technologies, announced a pilot collaboration that they said “will support the commercialization of each other’s products in the USA and UK, respectively, and offer strategic partners a scalable data platform.”
Click here to read the complete article.
Originally published November 5, 2015.